Can a Thigh-Worn sensor outsmart dizziness questionnaires?
NCT ID NCT04782830
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study explores whether a small accelerometer worn on the thigh can objectively measure how well treatments work for neurogenic orthostatic hypotension—a condition causing dizziness and fainting upon standing. Participants wear the device for one week on placebo and one week on their usual medication (midodrine or atomoxetine). The goal is to see if upright time measured by the device matches or outperforms symptom questionnaires in assessing treatment effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- accelerometer (Activpal device)
- What this could lead to
- If successful, this could provide a more objective way to measure how well treatments for orthostatic hypotension work, improving future care.
- What could go wrong
- This is a small, early-stage study focused on measurement methods, not a treatment itself. The device may not prove superior to standard questionnaires.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMIC FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?